Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease
- PMID: 28984583
- PMCID: PMC5757649
- DOI: 10.3233/JAD-170545
Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease
Abstract
Prevention of dementia due to Alzheimer's disease (d/AD) requires interventions that slow the disease process prior to symptom onset. To develop such interventions, one needs metrics that assess pre-symptomatic disease progression. Familiar measures of progression include cerebrospinal fluid (CSF) biochemical and imaging analyses, as well as cognitive testing. Changes in the latter can sometimes be difficult to distinguish from effects of "normal" aging. A different approach involves testing of "central auditory processing" (CAP), which enables comprehension of auditory stimuli amidst a distracting background (e.g., conversation in a noisy bar or restaurant). Such comprehension is often impaired in d/AD. Similarly, effortful or diminished auditory comprehension is sometimes reported by cognitively healthy elders, raising the possibility that CAP deficit may be a marker of pre-symptomatic AD. In 187 cognitively and physically healthy members of the aging, AD family history-positive PREVENT-AD cohort, we therefore evaluated whether CAP deficits were associated with known markers of AD neurodegeneration. Such markers included CSF tau concentrations and magnetic resonance imaging volumetric and cortical thickness measures in key AD-related regions. Adjusting for age, sex, education, pure-tone hearing, and APOEɛ4 status, we observed a persistent relationship between CAP scores and CSF tau levels, entorhinal and hippocampal cortex volumes, cortical thickness, and deficits in cognition (Repeatable Battery for Assessment of Neuropsychological Status total score, and several of its index scales). These cross-sectional observations suggest that CAP may serve as a novel metric for pre-symptomatic AD pathogenesis. They are therefore being followed up longitudinally with larger samples.
Keywords: Biomarkers; central auditory processing disorder; cognitive function; pre-clinical Alzheimer’s disease; prevention; sensorineural assessment.
Figures


Similar articles
-
Odor identification as a biomarker of preclinical AD in older adults at risk.Neurology. 2017 Jul 25;89(4):327-335. doi: 10.1212/WNL.0000000000004159. Epub 2017 Jun 28. Neurology. 2017. PMID: 28659431 Free PMC article.
-
Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176. J Alzheimers Dis. 2016. PMID: 27472875
-
Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease.J Alzheimers Dis. 2019;70(4):1051-1058. doi: 10.3233/JAD-190519. J Alzheimers Dis. 2019. PMID: 31306137 Free PMC article.
-
[Biomarkers in Alzheimer's disease].Rev Neurol. 2014 Apr 1;58(7):308-17. Rev Neurol. 2014. PMID: 24677154 Review. Spanish.
-
Design considerations for characterizing psychiatric trajectories across the lifespan: application to effects of APOE-ε4 on cerebral cortical thickness in Alzheimer's disease.Am J Psychiatry. 2011 Sep;168(9):894-903. doi: 10.1176/appi.ajp.2011.10111690. Epub 2011 Jul 1. Am J Psychiatry. 2011. PMID: 21724665 Free PMC article. Review.
Cited by
-
Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease.Neuroimage Clin. 2021;31:102733. doi: 10.1016/j.nicl.2021.102733. Epub 2021 Jun 17. Neuroimage Clin. 2021. PMID: 34192666 Free PMC article.
-
Speech Understanding in Modulated Noise and Speech Maskers as a Function of Cognitive Status in Older Adults.Am J Audiol. 2021 Sep 10;30(3):642-654. doi: 10.1044/2021_AJA-20-00177. Epub 2021 Jul 27. Am J Audiol. 2021. PMID: 34314238 Free PMC article.
-
Hearing impairment and dementia: cause, catalyst or consequence?J Neurol. 2025 May 16;272(6):402. doi: 10.1007/s00415-025-13140-x. J Neurol. 2025. PMID: 40377748 Free PMC article. Review.
-
Predicting Brain Amyloid Status Using the National Institute of Health Toolbox (NIHTB) for Assessment of Neurological and Behavioral Function.J Prev Alzheimers Dis. 2024;11(4):943-957. doi: 10.14283/jpad.2024.77. J Prev Alzheimers Dis. 2024. PMID: 39044505 Free PMC article.
-
Cognitive Flexibility and Inhibition in Individuals with Age-Related Hearing Loss.Geriatrics (Basel). 2021 Mar 5;6(1):22. doi: 10.3390/geriatrics6010022. Geriatrics (Basel). 2021. PMID: 33807842 Free PMC article.
References
-
- Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med 367, 795–804. - PMC - PubMed
-
- Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7, 280–292. - PMC - PubMed
-
- Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L (2000) The course of cognitive impairment in preclinical Alzheimerdisease: Three-and 6-year follow-up of a population-based sample. Arch Neurol 57, 839–844. - PubMed
-
- Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in “normal” aging: Evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 46, 707–719. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous